87
Views
8
CrossRef citations to date
0
Altmetric
Original Research

A longitudinal, retrospective cohort study on the impact of roflumilast on exacerbations and economic burden among chronic obstructive pulmonary disease patients in the real world

, , , , &
Pages 2127-2136 | Published online: 07 Oct 2015

References

  • VestboJHurdSSAgustiAGGlobal strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summaryAm J Respir Crit Care Med2013187434736522878278
  • Health United StatesWith Special Feature on Death and Dying2010 Available from: http://www.cdc.gov/nchs/data/hus/hus10.pdf#specialfeature
  • HoyertDLXuJDeaths: preliminary data for 2011Natl Vital Stat Rep201261616524984457
  • MapelDWHurleyJSFrostFJPetersenHVPicchiMACoultasDBHealth care utilization in chronic obstructive pulmonary disease: a case-control study in a health maintenance organizationArch Intern Med200016017265310999980
  • DALIRESP® (Roflumilast) [Package Insert]St Louis, MOForest Pharmaceuticals, Inc Available from: http://frx.com/pi/Daliresp_pi.pdf
  • DeyoRACherkinDCCiolMAAdapting a clinical comorbidity index for use with ICD-9-CM administrative databasesJ Clin Epidemiol19924566136191607900
  • LindenauerPKPekowPSLahtiMCLeeYBenjaminEMRothbergMBAssociation of corticosteroid dose and route of administration with risk of treatment failure in acute exacerbation of chronic obstructive pulmonary diseaseJAMA2010303232359236720551406
  • MapelDWDutroMPMartonJPWoodruffKMakeBIdentifying and characterizing COPD patients in US managed care. A retrospective, cross-sectional analysis of administrative claims dataBMC Health Serv Res2011114321345188
  • DalalAAChristensenLLiuFRiedelAADirect costs of chronic obstructive pulmonary disease among managed care patientsInt J Chron Obstruct Pulmon Dis2010534121037958
  • BarberJThompsonSMultiple regression of cost data: use of generalised linear modelsJ Health Serv Res Policy20049419720415509405
  • LichtenbergFRSunSXThe impact of Medicare part D on prescription drug use by the elderlyHealth Aff200726617351744
  • FabbriLMCalverleyPIzquierdo-AlonsoJLRoflumilast in moderate-to-severe chronic obstructive pulmonary disease treated with long-acting bronchodilators: two randomised clinical trialsLancet2009374969169570319716961
  • CalverleyPRabeKFGoehringU-MKristiansenSFabbriLMMartinezFJRoflumilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trialsLancet2009374969168569419716960
  • AbuDaggaASunSXTanHSolemCTHealthcare utilization and costs among chronic bronchitis patients treated with maintenance medications from a US managed care populationJ Med Econ201316342142923336296
  • DarnellKDwivediAKWengZPanosRJDisproportionate utilization of healthcare resources among veterans with COPD: a retrospective analysis of factors associated with COPD healthcare costCost Eff Resour Alloc20131111323763761
  • JohannesdottirSAChristiansenCFJohansenMBHospitalization with acute exacerbation of chronic obstructive pulmonary disease and associated health resource utilization: a population-based Danish cohort studyJ Med Econ201316789790623621504
  • PasqualeMKSunSXSongFHartnettHJStemkowskiSAImpact of exacerbations on health care cost and resource utilization in chronic obstructive pulmonary disease patients with chronic bronchitis from a predominantly Medicare populationInt J Chron Obstruct Pulmon Dis2012775723152680
  • DonaldsonGSeemungalTPatelILloyd-OwenSWilkinsonTWedzichaJLongitudinal changes in the nature, severity and frequency of COPD exacerbationsEur Respir J200322693193614680081
  • MittmannNKuramotoLSeungSHaddonJBradley-KennedyCFitzgeraldJThe cost of moderate and severe COPD exacerbations to the Canadian healthcare systemRespir Med2008102341342118086519
  • LlorCMolinaJNaberanKCotsJRosFMiravitllesMExacerbations worsen the quality of life of chronic obstructive pulmonary disease patients in primary healthcareInt J Clin Pract200862458559218266710
  • SteinBDBautistaASchumockGTThe validity of international classification of diseases, ninth revision, clinical modification diagnosis codes for identifying patients hospitalized for COPD exacerbations validity of diagnosis codes in COPD exacerbationsChest20121411879321757568
  • CalverleyPMSanchez-TorilFMcIvorATeichmannPBredenbroekerDFabbriLMEffect of 1-year treatment with roflumilast in severe chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2007176215416117463412
  • RabeKFFabbriLMVogelmeierCSeasonal distribution of COPD exacerbations in the prevention of exacerbations with tiotropium in COPD trialChest2013143371171923188489